Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Transcriptional regulation of the chicken CRHR2 gene by pituitary transcription factors.

Noy EB, Watanabe Y, Grommen SVH, De Groef B.

Gen Comp Endocrinol. 2019 Aug 24;284:113263. doi: 10.1016/j.ygcen.2019.113263. [Epub ahead of print]

PMID:
31454497
2.

Evolutionary origin of the type 2 corticotropin-releasing hormone receptor γ splice variant.

De Groef B, Wawrzyczek SK, Watanabe Y, Noy EB, Reser DH, Grommen SVH.

Genes Cells. 2019 Apr;24(4):318-323. doi: 10.1111/gtc.12673. Epub 2019 Mar 3.

3.

Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP-1.

Matalon O, Ben-Shmuel A, Kivelevitz J, Sabag B, Fried S, Joseph N, Noy E, Biber G, Barda-Saad M.

EMBO J. 2018 Mar 1;37(5). pii: e96264. doi: 10.15252/embj.201696264. Epub 2018 Feb 15.

4.

Molecular cloning and tissue distribution of Crh and Pomc mRNA in the fat-tailed dunnart (Sminthopsis crassicaudata), an Australian marsupial.

Noy EB, Scott MK, Grommen SVH, Robert KA, De Groef B.

Gene. 2017 Sep 5;627:26-31. doi: 10.1016/j.gene.2017.06.004. Epub 2017 Jun 3.

PMID:
28587847
5.

A conformational change within the WAVE2 complex regulates its degradation following cellular activation.

Joseph N, Biber G, Fried S, Reicher B, Levy O, Sabag B, Noy E, Barda-Saad M.

Sci Rep. 2017 Mar 23;7:44863. doi: 10.1038/srep44863.

6.

Male-to-female transitions: Implications for occupational performance, health, and life satisfaction.

Bar MA, Jarus T, Wada M, Rechtman L, Noy E.

Can J Occup Ther. 2016 Apr;83(2):72-82.

PMID:
26902095
7.

Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.

Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G.

Bioorg Med Chem. 2016 Jan 15;24(2):294-303. doi: 10.1016/j.bmc.2015.12.020. Epub 2015 Dec 12.

PMID:
26719208
8.

Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.

Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G.

Biopolymers. 2016 Mar;106(2):160-171. doi: 10.1002/bip.22800.

PMID:
26715008
9.

Design of Compact Biomimetic Cellulose Binding Peptides as Carriers for Cellulose Catalytic Degradation.

Khazanov N, Iline-Vul T, Noy E, Goobes G, Senderowitz H.

J Phys Chem B. 2016 Jan 21;120(2):309-19. doi: 10.1021/acs.jpcb.5b11050. Epub 2016 Jan 6.

PMID:
26691055
10.

REMD Simulations Reveal the Dynamic Profile and Mechanism of Action of Deleterious, Rescuing, and Stabilizing Perturbations to NBD1 from CFTR.

Zhenin M, Noy E, Senderowitz H.

J Chem Inf Model. 2015 Nov 23;55(11):2349-64. doi: 10.1021/acs.jcim.5b00312. Epub 2015 Oct 29.

PMID:
26418372
11.

Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity.

Momic T, Katzhendler J, Shai E, Noy E, Senderowitz H, Eble JA, Marcinkiewicz C, Varon D, Lazarovici P.

Drug Des Devel Ther. 2015 Jan 5;9:291-304. doi: 10.2147/DDDT.S72844. eCollection 2015.

12.

WASp family verprolin-homologous protein-2 (WAVE2) and Wiskott-Aldrich syndrome protein (WASp) engage in distinct downstream signaling interactions at the T cell antigen receptor site.

Pauker MH, Reicher B, Joseph N, Wortzel I, Jakubowicz S, Noy E, Perl O, Barda-Saad M.

J Biol Chem. 2014 Dec 12;289(50):34503-19. doi: 10.1074/jbc.M114.591685. Epub 2014 Oct 23.

13.

WIP: more than a WASp-interacting protein.

Fried S, Matalon O, Noy E, Barda-Saad M.

J Leukoc Biol. 2014 Nov;96(5):713-27. doi: 10.1189/jlb.2RU0314-162R. Epub 2014 Sep 10. Review.

PMID:
25210148
14.

Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex.

Fried S, Reicher B, Pauker MH, Eliyahu S, Matalon O, Noy E, Chill J, Barda-Saad M.

Sci Signal. 2014 Jun 24;7(331):ra60. doi: 10.1126/scisignal.2005198.

PMID:
24962707
15.

Vimocin and vidapin, cyclic KTS peptides, are dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity.

Momic T, Katzehendler J, Benny O, Lahiani A, Cohen G, Noy E, Senderowitz H, Eble JA, Marcinkiewicz C, Lazarovici P.

J Pharmacol Exp Ther. 2014 Sep;350(3):506-19. doi: 10.1124/jpet.114.214643. Epub 2014 Jun 17.

PMID:
24939421
16.

Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state.

Layani-Bazar A, Skornick I, Berrebi A, Pauker MH, Noy E, Silberman A, Albeck M, Longo DL, Kalechman Y, Sredni B.

Cancer Res. 2014 Jun 1;74(11):3092-103. doi: 10.1158/0008-5472.CAN-13-2159. Epub 2014 Apr 3.

17.

Real-time live imaging of T-cell signaling complex formation.

Noy E, Pauker MH, Barda-Saad M.

J Vis Exp. 2013 Jun 23;(76). doi: 10.3791/50076.

18.

WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions.

Noy E, Fried S, Matalon O, Barda-Saad M.

Int J Mol Sci. 2012;13(6):7629-47. doi: 10.3390/ijms13067629. Epub 2012 Jun 21. Review.

19.

Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.

Hudson RP, Chong PA, Protasevich II, Vernon R, Noy E, Bihler H, An JL, Kalid O, Sela-Culang I, Mense M, Senderowitz H, Brouillette CG, Forman-Kay JD.

J Biol Chem. 2012 Aug 17;287(34):28480-94. doi: 10.1074/jbc.M112.371138. Epub 2012 Jun 21.

20.

Studying the dynamics of SLP-76, Nck, and Vav1 multimolecular complex formation in live human cells with triple-color FRET.

Pauker MH, Hassan N, Noy E, Reicher B, Barda-Saad M.

Sci Signal. 2012 Apr 24;5(221):rs3. doi: 10.1126/scisignal.2002423.

21.

Combating cystic fibrosis: in search for CF transmembrane conductance regulator (CFTR) modulators.

Noy E, Senderowitz H.

ChemMedChem. 2011 Feb 7;6(2):243-51. doi: 10.1002/cmdc.201000488. Epub 2011 Jan 14. Review. No abstract available.

PMID:
21275046
22.

Flexible protein-protein docking based on Best-First search algorithm.

Noy E, Goldblum A.

J Comput Chem. 2010 Jul 15;31(9):1929-43. doi: 10.1002/jcc.21480.

PMID:
20087902
24.

Stochastic algorithm for kinase homology model construction.

Rayan A, Noy E, Chema D, Levitzki A, Goldblum A.

Curr Med Chem. 2004 Mar;11(6):675-92.

PMID:
15032723

Supplemental Content

Support Center